[
Home ] [ Hazards & Disasters ] [
Human Events ] [
Chemical Agents ]
GF
GF
is a liquid organophosphate nerve agent with an intermediate persistence
(evaporation rate about 1/20th of water). It has a nondescript odor
(20 test subjects: 35% smelled an odor at 10.4 mg/m3; 65% at 14.8 mg/m3;
odor was variously described as sweet, musty, peaches, and shellac).
Synonyms: CMPF, Cyclosarin, Cyclosin, O-Cyclohexyl methylphosphonofluoridate,
Cyclohexyl methylphosphonofluoridate, Methyl cyclohexylfluorophosphonate
Boiling Point 239°; Freezing Point -30°; Flammable; Flash Point
94°
DETECTION: Nerve agent sensitive chemical agent detectors (e.g.,
CAM, M18A2, M256, etc.) and papers (e.g., M8, M9) may be used for detection.
History: Cyclosarin was probably first synthesized during World
War II as part of the systematic study of organophosphates undertaken
by the Germans after their potential military utility was identified.
It was again looked at in the early 1950's by the United States and
Great Britain as both countries undertook a systematic study of potential
nerve agents. However, the higher cost of the precursors for GF relative
to those for GB along with its lower toxicity prevented it from being
chosen for manufacture.
SYMPTOMS AND EFFECTS: Lowered acetylcholinesterase levels are
indicators of nerve agent intoxication in victims.
Depending on the degree of intoxication, symptoms may include:
- Nervousness/Restlessness
- Miosis
(contraction of the pupil)
- Rhinorrhea
(runny nose), excessive salivation
- Dyspnea
(difficulty in breathing due to
bronchoconstriction/secretions)
- Sweating
- Bradycardia
(slow heartbeat)
- Loss of
consciousness
- Convulsions
- Flaccid
paralysis
- Loss of
bladder and bowel control
- Apnea (breathing
stopped)
|
Onset is usually
rapid, occurring within minutes of exposure.
MEDICAL COUNTERMEASURES: The immediate treatment for nerve agent
intoxication is intravenous injection of 2 mg atropine sulfate (intramuscular
injection should be considered if the patient is hypoxic and ventilation
can not be initiated, as there is a risk of ventricular fibrillation).
This should be followed by additional injections of atropine at 10-15
minute intervals, continuing until bradycardia has been reversed (e.g.,
until the heart rate is at 90 beats/minute). If breathing has stopped,
a mechanical respirator should be used to ventilate the patient. DO
NOT ATTEMPT
MOUTH-TO-MOUTH RESUCITATION. If possible, oxygen or oxygen-enriched
air should be used for ventilation. If possible, monitor cardiac activity.
Oximes (pralidoxime salts, obidoxime) may be of use in restoring acetylcholinesterase
activity. Obidoxime may be used to treat GF intoxication; however, it
may cause liver damage. Animal studies indicate that the oxime Hi-6
may be significantly superior to other oximes in the treatment of GF
intoxication, but it is not widely available. Therefore pralidoxime
salts should be used, with a slow intravenous infusion of 500 mg to
1 g being given initially.
Diazepam should be administered to control convulsions. It also has
value in controlling fear on the part of the patient. An initial dose
of 5 mg may be followed by additional doses at 15 minute intervals up
to a total of 15 mg.
PHYSICAL COUNTERMEASURES: Initial Isolation and Protective Action
Distances
SMALL
RELEASE: (small package/leaking container);
First ISOLATE in all directions 100 ft. (30meter)
Then PROTECT persons downwind at least 0.2 mi (0.3 km)
LARGE RELEASE: (large package/multiple small packages)
First ISOLATE in all directions 800ft. (250meter)
Then PROTECT persons downwind during at least 1.5 miles (2.5 km) |
Protective equipment (self-contained breathing equipment or gas mask,
barrier suit) must be used. Medical personnel treating casualties should
avoid direct (skin-to skin) contact; protective gear including breathing
protection should be worn when treating casualties prior to decontamination.
Latex gloves are not adequate protection. Casualties should be removed
from exposure and decontaminated as rapidly as possible. Casualties
must not be moved into clean treatment areas where unmasked/ungloved
personnel are working until decontamination is complete.
2000 Emergency Response Guidebook (ERG2000) Guide 153.
DECONTAMINATION
People: Decontamination of victims is accomplished by removing the victim
from the contaminated area, removal of clothing, and removal or neutralization
of agent present on the skin (skin decontamination may be unnecessary
if the exposure was only to GF vapor). Any visible droplets should be
blotted (not wiped) away using an absorbent material (e.g., paper towels,
facial tissues, etc.); if available, towelettes moistened with a neutralizing
solution should be used. Adsorbent powders may also be used for removal
of droplets (in the absence of standard adsorbents, field expedients
such as flour may be useful). A solution of 0.5% hypochlorite bleach
may be used for skin decontamination. Hair should be thoroughly cleaned
using soap and water, with care being taken to prevent wash water from
contacting skin.
Property: Surface decontamination may be accomplished using hypochlorite
bleach slurries, dilute alkalis, or DS2 decontaminating solution. Steam
and ammonia may be used for the decontamination of confined spaces.
GF is only slightly soluble in water and the liquid, if present in relatively
large amounts, can layer out at the bottoms of pools.
|